Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Name</td><td class="align_center"><i>n</i></td><td class="align_center">SZL (<i>μ</i>mol/L)</td><td class="align_center">SZL-medicated serum (nmol/L)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Albiflorin</td><td class="align_center">4</td><td class="align_center">2619.21 ± 129.13</td><td class="align_center">ND</td></tr><tr><td class="align_left">Cinnamic acid</td><td class="align_center">4</td><td class="align_center">1168.93 ± 55.36</td><td class="align_center">1005.60 ± 51.06</td></tr><tr><td class="align_left">Glycyrrhizic acid</td><td class="align_center">4</td><td class="align_center">7564.53 ± 1079.91</td><td class="align_center">32945.61 ± 31235.12</td></tr><tr><td class="align_left">Liquiritin</td><td class="align_center">4</td><td class="align_center">1027.11 ± 50.39</td><td class="align_center">38.96 ± 10.90</td></tr><tr><td class="align_left">Paeoniflorin</td><td class="align_center">4</td><td class="align_center">6938.82 ± 453.27</td><td class="align_center">72.84 ± 20.14</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>ND indicates that the target compound in this sample was not detected.<br/></div></td></tr></table>

<div>Metabolite concentrations in SZL and SZL-medicated serum.</div>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway 